Abstract: A method for face image processing is provided. The method includes the follows. A face image is recognized to obtain a recognition result. An image adjustment parameter set is obtained according to the recognition result. A deflection angle of a face in the face image relative to a reference face in a reference face image is determined. A target image adjustment parameter is selected from the image adjustment parameter set according to the deflection angle. The face image is processed according to the target image adjustment parameter. A device for face image processing, a storage medium, and an electronic device are further provided.

Abstract: A basic oxygen furnace slag treatment method includes the steps of mixing basic oxygen furnace slag with an active aqueous solution and then keeping the mixture thus obtained under an enclosed environment for reaction and then employing a solid-liquid separation procedure to separate solid phase from liquid phase. Since basic oxygen furnace slag has strong alkaline, the method of the invention overcomes the problem that directly discharging basic oxygen furnace slag will cause environmental pollutions. The basic oxygen furnace slag treatment method avoids a secondary pollution, and can turn waste into treasure, bringing a number of economic benefits.

Abstract: Methods to isolate and expand tumor specific CD8+ T cells, and the use thereof, are provided. Also provided are method of using TLR7 agonists.

Abstract: An illumination system including a first excitation light source, a transflective element, a wavelength conversion wheel and a filter wheel is provided. The first excitation light source emits a first excitation beam. The transflective element allows a first portion beam of the first excitation beam to pass through, and reflects a second portion beam of the first excitation beam. The wavelength conversion wheel is disposed on a transmission path of the first portion beam and includes a wavelength conversion region, and when the first portion beam irradiates onto the wavelength conversion region, the first portion beam is converted into a converted beam. The filter wheel is disposed on a transmission path of the second portion beam and the converted beam, and includes multiple filter regions, wherein the second portion beam and the converted beam irradiate onto each of the filter regions of the filter wheel.

Abstract: A method for desulfurization and dezincification of tailings includes the step of passing tap water into a high oxidation reduction electrocatalytic water equipment to reduce the pH value of tap water to 1-2, mixing a specific ratio of the pH value 1-2 acid electrocatalytic water with low-quality high-sulfur iron in the tailings, heating the mixture to let H+ in the acid electrocatalytic water be reacted with sulfur and zinc in the low-quality high-sulfur iron and to further cause generation of an ion state of hydrogen sulfide gas where the volatilization of water vapor effectively removes the sulfur and zinc elements in the low-quality high-sulfur iron and the hydrogen sulfide gas thus generated is collected.

Abstract: A method for desulfurization and dezincification of high-sulfur coal includes the steps of passing tap water into a high oxidation reduction electrocatalytic water equipment to reduce the pH value to 1-2, mixing the pH value 1-2 acid electrocatalytic water thus obtained with the high-sulfur coal, and heating the mixture to let H+ in the acid electrocatalytic water be reacted with sulfur and nitrogen in the high-sulfur coal to cause generation of hydrogen sulfide gas and ammonia where the volatilization of water vapor effectively removes the sulfur and nitrogen in the high-sulfur coal and the hydrogen sulfide and ammonia gases thus generated are collected.

Abstract: An illumination system including an exciting light source module, a beam splitting and combining module, a wavelength conversion component and a light filtering component is provided. The exciting light source module is adapted to emit an exciting beam. The beam splitting and combining module is disposed on a transmission path of the exciting beam. The wavelength conversion component has a first optical region and a second optical region, and the first optical region and the second optical region are sequentially cut into the transmission path of the exciting beam transmitted by the beam splitting and combining module. The light filtering component is combined with the wavelength conversion component by a common central axis, so that the wavelength conversion component and the light filtering component are adapted to rotate coaxially. The illumination system has a simpler structure and lower cost. A projection apparatus is also provided.

Abstract: The present invention provides a hexa-lactoside-triazanonane triacetic acid (NOTA) derivative, a method for radiolabeling a hexa-lactoside positron emission tomography (PET) imaging agent for a liver receptor with Ga-68, and a hexa-lactoside PET imaging agent for a liver receptor. The hexa-lactoside-NOTA derivative is a conjugate of six chains of lactose with NOTA obtained by conjugating hexa-lactoside to a chelating agent p-thiocyanate-benzyl-triazanonane diacetic acid-glutamic acid in the presence of triethyl amine/dimethyl formamide as a solvent. The radiolabeling method comprises labeling with Ga-68 at room temperature. According to the present invention, the labeling effect is stable, the labeling efficiency of the labeled product is greater than 95%, the labeled product is highly stable and the radiochemical purity is still greater than 90% after 4 hours.

Abstract: A construction method for a (n,n(n?1),n?1) permutation group code based on coset partition is provided. The presented (n,n(n?1),n?1) permutation group code has an error-correcting capability of d?1 and features a strong anti-interference capability for channel interferences comprising multi-frequency interferences and signal fading. As n is a prime, for a permutation code family with a minimum distance of n?1 and a code set size of n(n?1), the invention provides a method of calculating n?1 orbit leader permutation codewords by On={?o1}?=1n-1(mod n) and enumerating residual codewords of the code set by Pn=CnOn={(l1)n-1On}={(rn)n-1On}. Besides, a generator of the code set thereof is provided. The (n,n(n?1),n?1) permutation group code of the invention is an algebraic-structured code, n?1 codewords of the orbit leader array can be obtained simply by adder and (mod n) calculator rather than multiplication of positive integers.

Abstract: A construction method for a (n,n(n?1),n?1) permutation group code based on coset partition is provided. The presented (n,n(n?1),n?1) permutation group code has an error-correcting capability of d?1 and features a strong anti-interference capability for channel interferences comprising multi-frequency interferences and signal fading. As n is a prime, for a permutation code family with a minimum distance of n?1 and a code set size of n(n?1), the invention provides a method of calculating n?1 orbit leader permutation codewords by On={?o1}?=1n?1(mod n) and enumerating residual codewords of the code set by Pn=CnOn={(l1)n?1On}={(rn)n?1On)}. Besides, a generator of the code set thereof is provided. The (n,n(n?1),n?1) permutation group code of the invention is an algebraic-structured code, n?1 codewords of the orbit leader array can be obtained simply by adder and (mod n) calculator rather than multiplication of positive integers.

Abstract: The present invention is related to a radiolabeled active targeting pharmaceutical composition, including: a bioconjugate and a radionuclide, wherein the bioconjugate includes a biomolecule and a metal nanoparticle, wherein the biomolecule has an affinity for receptors on the surface of a cell membrane and is selected from the group consisting of a peptide and a protein. The present invention further provides a method for evaluating a thermal adjuvant therapy for tumors and a kit thereof. The above-mentioned pharmaceutical composition is applied to evaluate a tumor accumulation time, so as to establish the optimal policy for a radiofrequency- or laser-induced thermal adjuvant therapy for tumors.

Abstract: Disclosed herein is a bispecific peptide conjugate comprising an epidermal growth factor receptor (EGFR) targeting peptide, an ?v?3 integrin targeting peptide, and a linker, where the linker is conjugated respectively to the EGFR targeting peptide and the ?v?3 integrin targeting peptide.

Abstract: The present invention is related to a radiolabeled active targeting pharmaceutical composition, including: a bioconjugate and a radionuclide, wherein the bioconjugate includes a biomolecule and a metal nanoparticle, wherein the biomolecule has an affinity for receptors on the surface of a cell membrane and is selected from the group consisting of a peptide and a protein. The present invention further provides a method for evaluating a thermal adjuvant therapy for tumors and a kit thereof. The above-mentioned pharmaceutical composition is applied to evaluate a tumor accumulation time, so as to establish the optimal policy for a radiofrequency- or laser-induced thermal adjuvant therapy for tumors.

Abstract: A basic oxygen furnace slag treatment method includes the steps of mixing basic oxygen furnace slag with an active aqueous solution and then keeping the mixture thus obtained under an enclosed environment for reaction and then employing a solid-liquid separation procedure to separate solid phase from liquid phase. Since basic oxygen furnace slag has strong alkaline, the method of the invention overcomes the problem that directly discharging basic oxygen furnace slag will cause environmental pollutions. The basic oxygen furnace slag treatment method avoids a secondary pollution, and can turn waste into treasure, bringing a number of economic benefits.

Abstract: A wavelength conversion device including a main body and a transparent element is provided. The main body has at least one wavelength conversion region, a containing recess portion, and a stop portion. The containing recess portion and the stop portion encircle a closed slot. The transparent element is disposed in the closed slot to construct a light penetration region. The stop portion stops the transparent element along a radial direction of the main body. Moreover, a projector using the wavelength conversion device is also mentioned.

Abstract: The present invention is related to a radiolabeled active targeting pharmaceutical composition, including: a bioconjugate and a radionuclide, wherein the bioconjugate includes a biomolecule and a metal nanoparticle, wherein the biomolecule has an affinity for receptors on the surface of a cell membrane and is selected from the group consisting of a peptide and a protein. The present invention further provides a method for evaluating a thermal adjuvant therapy for tumors and a kit thereof. The above-mentioned pharmaceutical composition is applied to evaluate a tumor accumulation time, so as to establish the optimal policy for a radiofrequency- or laser-induced thermal adjuvant therapy for tumors.

Abstract: There is provided a conjugate of a delivery agent containing a chemical moiety and at least one flavonoid. The flavonoid exists in a monomeric form or dimeric form before conjugation and remains in the monomeric form or dimeric form after conjugation. Preferably, the conjugate comprises two flavonoids. The delivery agent is conjugated at the C6 and/or the C8 position of the A ring of the flavonoid. An anti-cancer agent delivery vehicle comprising an anti-cancer agent and the conjugate is also provided.

Abstract: A construction method for a (n,n(n?1),n?1) permutation group code based on coset partition is provided. The presented (n,n(n?1),n?1) permutation group code has an error-correcting capability of d?1 and features a strong anti-interference capability for channel interferences comprising multi-frequency interferences and signal fading. As n is a prime, for a permutation code family with a minimum distance of n?1 and a code set size of n(n?1), the invention provides a method of calculating n?1 orbit leader permutation codewords by On={?o1}?=1n?1(mod n) and enumerating residual codewords of the code set by Pn=CnOn={(l1)n?1On}={(rn)n?1On)}. Besides, a generator of the code set thereof is provided. The (n,n(n?1),n?1) permutation group code of the invention is an algebraic-structured code, n?1 codewords of the orbit leader array can be obtained simply by adder and (mod n) calculator rather than multiplication of positive integers.

Abstract: There is provided a conjugate of a delivery agent containing a chemical moiety and at least one flavonoid. The flavonoid exists in a monomeric form or dimeric form before conjugation and remains in the monomeric form or dimeric form after conjugation. Preferably, the conjugate comprises two flavonoids. The delivery agent is conjugated at the C6 and/or the C8 position of the A ring of the flavonoid. An anti-cancer agent delivery vehicle comprising an anti-cancer agent and the conjugate is also provided.

Abstract: Various embodiments of the present invention relate to a multilayered structure and a method of making the same. Various embodiments relate to a balloon including the multilayered structure. In various embodiments, the present invention provides a multilayered structure that can include a layer (a) including a cyclic olefin polymer or copolymer and an olefin polymer or copolymer. The multilayered structure can also include a layer (b) comprising a cyclic olefin polymer or copolymer and an olefin polymer or copolymer. Layer (a) can be substantially in contact with layer (b).